References
- Vinik AI, McLeod MK, Fig LM, Shapiro B, Lloyd R, Cho K. Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989;18:865–96.
- Moertel CG. Karnofsky Memorial Lecture: an odyssey in the land of small tumors. J Clin Oncol 1987;5:1503–22.
- Kulke M, Mayer R. Carcinoid tumors. N Engl J Med 1999;340: 858–68.
- Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813–29.
- Capella C, Heutz PU, Hofler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 1995;425:547–60.
- Kwekkeboom D, Krenning EP. Somatostatin receptor scintigraphy in patients with carcinoid tumors. World J Surg 1996;20:157–61.
- Krenning EP, Kwekkeboom D, de Jong M, Visser T, Reubi J, Bakker W, et al. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Semin Oncol 1994; 5 Suppl 13:6–14.
- Raderer M, Kurtaran A, Leimer M, Angelberger P, Niederle B, Vierhapper H, et al. Value of peptide receptor scintigraphy using 123I-Vasoactive intestinal peptide (VIP) and 111In-DTPA-D- Phe1-Octreotide (OCT) in 194 carcinoid patients: Vienna University Experience 1993–1999. J Clin Oncol 2000;18:1331–6.
- Klöppel G. Classification of neuroendocrine tumors. Verh Dtsch Ges Path 1997;81:111–7.
- Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion 1994;55 Suppl 3:11–23.
- Kurtaran A, Raderer M, Müller C, Prokesch R, Kaserer K, Eibenberger K, et al. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis. J Nucl Med 1997;38:880–1.